Use of standard criteria for assessment of cancer vaccines.
Restifo
Nicholas P
NP
US National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. restifo@nih.gov <restifo@nih.gov>
Rosenberg
Steven A
SA
D014408:Biomarkers, Tumor; D019496:Cancer Vaccines; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D009369:Neoplasms / Q000517:prevention & control*; D012074:Remission Induction / Q000379:methods
D014408:Biomarkers, Tumor; D019496:Cancer Vaccines